Skip to main content
. 2020 Nov 12;21(22):8519. doi: 10.3390/ijms21228519

Table 1.

Demographic data and cerebrospinal fluid concentrations in patients with early-stage Parkinson′s disease.

Demographics n
Female/male (n) 26 14/12
Age (years) 26 63 ± 13 (41–84)
Education (number per Verhage level 1/2/3/4/5/6/7) 26 0/1/1/3/8/5/8
Disease duration (years) 26 2 (1–5)
Hoehn and Yahr stage (nr. per stage 1/1.5/2/2.5/3/4/5) 26 2/3/13/8/0/0/0
UPDRS III score 26 22 (6–38)
MMSE score 26 29 (23–30)
BDI score 22 8 (0–29)
BAI score 22 10 (1–21)
CSF Biomarker Levels
t-α-syn (pg/mL) 21 1271 (723–1950)
p-α-syn (pg/mL) 21 268 (165–354)
p-α-syn/t-α-syn (%) 21 18.9 (8.5–34.7)
NfL (pg/mL) 20 858 (307–4948)
Amyloid-β42 (ng/L) 26 931 (400−1211)
t-tau (ng/L) 26 186.5 (95.0–369.0)
p-tau (ng/L) 26 35.5 (20.0–78.0)

Data are mean ± SD and range or median and range unless specified otherwise. Abbreviations: CSF, cerebrospinal fluid. UPDRS-III, Unified Parkinson′s Disease Rating Scale Part III. MMSE, Mini-Mental State Examination. t-α-syn, total α-synuclein. p-α-syn, phosphorylated α-synuclein. t-tau, total tau. p-tau, phosphorylated tau. NfL, neurofilament light chain. BDI Beck Depression Inventory. BAI, Beck Anxiety Inventory.